|
Curr Opin Pharmacol
''Current Opinion'' is a collection of review journals on various disciplines of the life sciences. They were acquired by Elsevier in 1997. Each issue of each journal, which all are published bimonthly, contains one or more themed sections edited by scientists who specialise in the field and invite authors to contribute reviews aimed at experts and non-specialists. Each journal aims to cover all the major recent advances in its topic area, and to direct readers to the most important original research. Journals See also * Current Opinion (Lippincott Williams & Wilkins) References External links * {{Reed Elsevier Elsevier imprints Elsevier academic journals Publishing companies established in 1990 Review journals Academic journal series ... [...More Info...] [...Related Items...] OR: [Wikipedia] [Google] [Baidu] |
Elsevier
Elsevier () is a Dutch academic publishing company specializing in scientific, technical, and medical content. Its products include journals such as '' The Lancet'', ''Cell'', the ScienceDirect collection of electronic journals, '' Trends'', the '' Current Opinion'' series, the online citation database Scopus, the SciVal tool for measuring research performance, the ClinicalKey search engine for clinicians, and the ClinicalPath evidence-based cancer care service. Elsevier's products and services also include digital tools for data management, instruction, research analytics and assessment. Elsevier is part of the RELX Group (known until 2015 as Reed Elsevier), a publicly traded company. According to RELX reports, in 2021 Elsevier published more than 600,000 articles annually in over 2,700 journals; as of 2018 its archives contained over 17 million documents and 40,000 e-books, with over one billion annual downloads. Researchers have criticized Elsevier for its high profit m ... [...More Info...] [...Related Items...] OR: [Wikipedia] [Google] [Baidu] |
